Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
This project aims to evaluate the role of fully hybrid PET/MRI with 18FPSMA and multiparametric MR imaging (mpMRI) as one-stop approach for the diagnosis of clinically significant prostate cancer (csPCa). Our main hypothesis is that adding 18F-PSMA PET to mpMRI prior to biopsy, will reduce the number of false negative findings, while at the same time, allowing also to reduce the number of unnecessary prostate biopsies in patients with low-risk, clinically indolent PCa.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:
• Men at least 18 years of age referred with clinical suspicion of prostate cancer candidate for prostate biopsy
• Feasibility to undergo all procedures listed in protocol
• Ability to provide written informed consent
Locations
Other Locations
Italy
U.O. of Nuclear Medicine, ,Ospedale San Raffaele
RECRUITING
Milan
Contact Information
Primary
Maria Picchio, MD
Picchio.maria@hsr.it
02-26436117
Backup
Rachele Di Donato, PhD
didonato.rachele@hsr.it
02-26433639
Time Frame
Start Date: 2023-12-04
Estimated Completion Date: 2026-07
Participants
Target number of participants: 167
Treatments
single arm
Related Therapeutic Areas
Sponsors
Leads: IRCCS San Raffaele